Clinical trial
To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
NCT00141414 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141414 |
|---|---|
| Title | To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy. |
| Official title | Pregabablin Open-Label, Follow-On Safety Trial In Patients With Refractory Partial Epilepsy. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Epilepsy, Partial |
| Intervention type | Drug |
| Interventions | Pregabalin |
| Enrollment | 82 |
| Start date | Nov 1, 1997 |
| Completion | Oct 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Jan 1, 2007 |
| Countries | Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: